The company 23andMe is based out of San Francisco and is now left with a single board member, Wojcicki who controls 49.75 per ...

Consumer DNA testing company 23andMe is circling the drain. The company's CEO, Anne Wojcicki, plans to take the company ...

With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to ...

A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?

Over the past year, 23andMe set new corporate governance lows. CEO Anne Wojcicki now enters de facto “founder mode” after a ...

Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing ...

Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...

A spokesperson for 23andMe would not comment to NPR on what will happen to genetic data, except to express the company’s ...

Financial and security chaos at the once-pioneering genetic testing firm has intensified concerns about user data. Here's how ...

The blue-chip board and the startup star had been on a collision course for months. Here’s what really happened.

Anne Wojcicki, CEO of 23andMe, the struggling DNA testing company, doesn’t think this is the right time to examine her ...

Anne Wojcicki, the CEO of the consumer genetic testing company 23andMe (ME), is cautiously optimistic about the firm’s future ...